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ABSTRACT 
 
Structural variants (SVs) are physical changes in the structure of chromosomes and include 
both unbalanced copy number variants (CNVs) and balanced events (translocations, 
inversions and insertions). Many SVs constitute benign background variation and are found 
frequently in healthy individuals. Others may cause disease through gene disruption, deletion 
or duplication of dosage sensitive genes, or by disrupting the 3D structure of the genome. 
In this thesis, we have delineated the exact structure of rearranged chromosomes and 
performed breakpoint junction analysis to study mutational signatures and underlying 
mechanisms of formation. 
In paper I, we characterized and analyzed breakpoint junction sequences of 23 
cytogenetically balanced translocations with mate-pair whole genome sequencing (WGS) and 
17% of the translocations had microhomology and/or templated insertions in the breakpoint 
junctions, indicative of replication-based repair mechanisms. Genes were disrupted in 48% of 
breakpoints, highlighting a number of novel candidate genes and providing a molecular 
diagnosis in three cases. In paper II, we used targeted array comparative genomic 
hybridization and WGS to show that intragenic exonic duplications, formed through Alu-Alu 
fusion events, within MATN3 and IFT81 cause monogenic skeletal dysplasia disorders. 
Follow-up studies in primary cells and in zebrafish embryos showed that expression of a 
shorter IFT81 transcript alone is compatible with life. In paper III, we used WGS to 
investigate a benign complex chromosome rearrangement on chromosome 5p, detected in a 
healthy woman, which through unequal crossing-over during meiosis evolved into a 
pathogenic rearrangement including a duplication of the NIPBL gene in her daughter. In 
paper IV, we characterized the breakpoint junctions in 16 cytogenetically detected 
inversions. Contrary to what was expected, the vast majority of the resolved inversions were 
not mediated by inverted repeats through non-allelic homologous recombination. The 
mutational signatures in all the resolved inversions (11/16) indicate other mechanisms than 
ectopic recombination including replicative mechanisms in 2 cases. In paper V, we utilized 
WGS to perform a detailed characterization of 21 cases harboring multiple CNVs clustering 
on the same chromosome. The analysis revealed that multiple cellular mechanisms are 
involved in the formation of such SVs. 
In conclusion, the results of this thesis show that WGS is a powerful way to delineate the 
structure of balanced, unbalanced and complex SVs. These studies have identified disease-
causing aberrations, new candidate genes for further studies of neurodevelopmental disorders, 
and contributed to the understanding of how, when and why SVs arise.
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1 INTRODUCTION 
 
Structural variants (SVs) are physical changes in the structure of one or several chromosomes 
and can either be balanced (translocations, inversions, insertions) or unbalanced (copy 
number variants (CNVs); deletions, duplications). SVs may cause human disease by the 
disruption of genes or through copy number changes of dosage sensitive genes. In addition, 
structural variation of the genome can, apart from directly affecting specific genes, also 
change the genomic architecture and 3D structure of the DNA molecules, indirectly affecting 
genes by moving regulatory elements such as enhancers, promoters and silencers to a new 
location closer to or further away from target genes.  
SVs implicated in human disease can be unique (found only in a single individual/family with 
unique breakpoints) or recurrent (repeatedly formed with similar breakpoints in unrelated 
individuals). The mechanisms underlying the formation of recurrent and non-recurrent SVs 
differ; recurrent SVs are most commonly formed through errors during homologous 
recombination and non-recurrent SVs arise through DNA replication errors or mistakes 
during repair of double strand breaks in the DNA molecules (Carvalho and Lupski, 2016; 
Currall, et al., 2013). Some chromosomal regions are prone to recurrent rearrangements due 
to the local genomic architecture and diseases caused by such genomic rearrangements are 
generally referred to as genomic disorders (Lupski, 1998).  
In 1959 the first genetic aberration was identified; Trisomy 21, or Down syndrome, caused by 
a whole extra chromosome 21. This aberration is visible through a microscope and SVs 
involving smaller parts of chromosomes can also be microscopically visible through G-
banding of chromosomes, if the genomic segments involved are larger than ~5-10 Mb. 
Karyotyping with G-banding of chromosomes was introduced in the 1970s (Yunis and 
Sanchez, 1973), and is still commonly used in clinical practice. Fluorescence in situ 
hybridization (FISH) was introduced in the mid 1980s with fluorescent probes hybridizing to 
specific chromosomes or specific parts of a chromosome, and the genome resolution was 
improved to 100 kb - 1 Mb (Pinkel, et al., 1986). In mid 2000s, the microarray technique was 
introduced, and especially the array comparative genomic hybridization (aCGH) (Tchinda 
and Lee, 2006) was revolutionizing the clinical practice of detecting SVs, with a resolution of 
~50 kb, depending on amount and distribution of probes. However, aCGH only detects 
unbalanced SVs. Whole-genome sequencing (WGS) was introduced around 2010 (Metzker, 
2010) and has rapidly developed into a crucial tool for detailed characterization of SVs. As 
  2 
for now, the massive amount of data from WGS is limiting the use for WGS as a screening 
method for SVs, and it is currently mostly used to characterize SVs that have been detected 
through other methods. However, the tools for interpreting WGS data are currently being 
developed and tested for “WGS first” use. 
 
1.1  STRUCTURAL VARIATION IN THE HUMAN GENOME 
 
1.1.1 Normal structural genomic variation 
The human genome consists of approximately 3 billion DNA base pairs, of which less than 
2% consists of exons that codes for proteins. The remaining >98% is made up of regulatory 
sequences, repeat elements and pseudogenes, as well as non-coding genetic material that to a 
large extent still is of unknown function. This part of the genome was referred to as “junk 
DNA” for a long time, but the more the non-coding part of the genome is studied, the more 
interesting it gets and it is increasingly obvious that “junk DNA” is absolutely crucial for 
cells to function properly. A recent example is the multinational project called Synthetic 
Yeast 2.0, where the main purpose is to synthesize all the yeast chromosomes from scratch 
(Mitchell, et al., 2017). Some parts of the genome may be removed without obvious effects, 
while other parts of the non-coding DNA need to be intact for the yeast to survive; for 
example, deleting the subtelomeric DNA severely affected gene expression and caused 
silencing of genes that were not supposed to be silenced (Mitchell, et al., 2017).  
Ever since the human genome was sequenced and published (International Human Genome 
Sequencing, 2004), it has been clear that there is an enormous amount of normal variation 
among individuals (Genomes Project, et al., 2015). In the 1000 Genomes Project, the 
genomes of 2,504 individuals from 26 populations were reconstructed and found that a 
typical genome differed from the reference human genome at 4.1-5 million sites and 
structural variants affected ~20 million base pairs of sequence (Genomes Project, et al., 
2015). The specific normal variants in the genome vary between populations, and it is 
therefore important to sequence large numbers of individuals from as many populations as 
possible. On average, each individual carries ~25 variants in genes previously implicated in 
human disease (Genomes Project, et al., 2015) and the available databases of normal variants 
are crucial for filtering out the disease-causing variants from variants without clinical impact. 
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Short-read WGS allows for the detection of single nucleotide variants (SNVs), 
insertions/deletions (indels) and SVs (balanced and unbalanced) in a single experiment. The 
introduction of WGS has speeded up the amount of human genomes sequenced and hence the 
detection of normal background variation. Today, we know that some genes can be 
completely knocked out without an apparent phenotypic effect, while others are highly 
sensitive to variation (Sudmant, et al., 2015). 
 
1.1.2 Role of repeat elements in structural genomic variation 
Over 50% of the human genome consists of repetitive sequences, so called repeat elements, 
that are present in multiple copies throughout the genomic sequence (de Koning, et al., 2011). 
Repeat elements are commonly divided into subgroups based on their structure and 
characteristics, for example tandem repeats (e.g. microsatellites, telomeres), interspersed 
repeats (e.g. mobile elements, pseudogenes) and low copy repeats (LCRs, or segmental 
duplications). We know the function or part of the function of some of these repeat elements, 
such as the sequences that comprise the telomeres that are crucial for chromosome dynamics 
during cell replication (Blackburn, 1991), or mobile elements that are widely recognized as 
drivers of genetic evolution (Kazazian, 2004). 
However, we also know that some repeat elements are the underlying cause of recurrent 
structural genomic rearrangements, of which some cause disease. A common example of how 
repeat elements predispose to disease-causing structural variants is the 17p deletions and 
duplications. The proximal p-arm of chromosome 17 is both gene- and LCR-rich and has 
been described in numerous cases with different rearrangements in constitutional and cancer-
associated chromosomal aberrations (Barbouti, et al., 2004; Pentao, et al., 1992; Stankiewicz, 
et al., 2004). In a ~7.5 Mb region on 17p that was investigated in a paper by Stankiewicz et 
al., it was found that LCRs constituted over 23% of the genomic sequence, explaining why 
this particular part of the genome seems to be more unstable than other genomic regions 
(Stankiewicz, et al., 2003).  
Unstable regions of the genome are still detected, and different types of repetitive elements 
seem to be responsible for, and predispose to, different types of rearrangements. 
Investigations of various diseases and genes have demonstrated the role of Alu elements in 
the formation of SVs (Boone, et al., 2011; Boone, et al., 2014; Gu, et al., 2015; Song, et al., 
2018). Alu elements are repetitive sequences belonging to the primate-specific short 
interspersed nuclear element (SINE) family of mobile DNA elements. They comprise ~11% 
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of the human genome and are present in more than 1 million copies in a haploid genome 
(Lander, et al., 2001). In a large study including 65 families with uncharacterized ciliopathies, 
a small (6.7 kb) tandem duplication in IFT140 was identified in eight families (Geoffroy, et 
al., 2018). It was found that the duplication was not a founder variant, but that the breakpoints 
overlapped distinct Alu elements with high sequence identity (68-81%) and resulted in an Alu 
hybrid on both sides of the duplication (Geoffroy, et al., 2018). In a recent study by Song et 
al., addressing the genomic instability caused by Alu elements, 12,074 OMIM genes were 
tested for the relative risk of Alu-Alu mediated rearrangements and 47 duplications, 40 
deletions and two complex rearrangements were fine-mapped (Song, et al., 2018). It was 
found that 94% of the candidate breakpoints were at least partially mediated by Alu elements, 
further strengthening the role of Alu elements in gene and genome evolution as well as in 
mediating human disease (Song, et al., 2018). 
 
1.2 STRUCTURAL VARIATION IN HUMAN DISEASE 
 
1.2.1 Balanced chromosomal aberrations   
The overall incidence of balanced chromosomal aberrations (BCAs), such as translocations 
(Figure 1A), inversions (Figure 1B-C) or insertions (Figure 1D), has been estimated in to be 
approximately 0.2% in an unselected newborn population (Jacobs, et al., 1992). In the same 
study, it was calculated that about 20% of translocations occur de novo with an estimated 
mutational rate of 2.7e-4 per gamete per generation (Jacobs, et al., 1992). Cytogenetic 
investigation of couples experiencing recurrent pregnancy loss is standardized and is the most 
common reason why BCAs in individuals with no other clinical phenotype are found (Jacobs, 
1987). Due to a risk of malsegregation of the rearranged chromosomes and errors in meiotic 
recombination, BCA carriers have an increased risk of having children with unbalanced 
rearrangements causing severe disease. 
It has been estimated that about 6% of de novo reciprocal balanced translocations are 
associated with a serious congenital anomaly, apparent before 1 year of age (Warburton, 
1991). Even though a significantly higher prevalence of BCAs has been identified in cohorts 
with neurodevelopmental disorders (1.5%) (Funderburk, et al., 1977) and autism spectrum 
disorder (ASD, 1.3%) (Marshall, et al., 2008), there are no solid numbers on the amount of 
mildly affected (mild intellectual disability, ADHD, dyslexia, learning difficulties) balanced 
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translocation carriers. A recent study with long-term follow-up (mean follow-up time 17 
years) showed that 26.8% of the de novo BCA carriers that were investigated presented with 
a clinical diagnosis, of which most were neurodevelopmental disorders (Halgren, et al., 
2018). The study suggests that the risk for mild neurodevelopmental disorders that are not 
obvious within the first year of life in de novo BCA carriers could be 2-3-fold higher than the 
risk for severe congenital diseases or malformations (predicted to approximately 6%), and 
that more studies with long-term follow-up are needed (Halgren, et al., 2018). BCAs 
disrupting single genes may help pinpoint directly disease-causing loci (Bramswig, et al., 
2017; Hofmeister, et al., 2015). In addition, it has been shown that recurrent inversions in 
especially unstable chromosomal regions cause no clinical phenotype in the carrier, but can 
increase the risk of microdeletions forming in the offspring, as in the case of Williams-
Beuren syndrome (MIM:194050, 7q11.23) and Prader-Willi syndrome/Angelman syndrome 
(MIM:176270/MIM:105830, 15q11-q13) (Gimelli, et al., 2003; Osborne, et al., 2001).  
Pinpointing the exact breakpoints is crucial for determining whether a balanced chromosomal 
aberration is involved in the clinical phenotype presented by the carrier. Historically, time 
consuming mapping of cytogenetically balanced chromosomal aberrations using pulse-field 
gel electrophoresis was a successful approach to new gene discovery with one prominent 
example being NF1 (causing neurofibromatosis type 1, MIM:162200) (Fountain, et al., 
1989). With use of WGS, breakpoint mapping and disease gene discovery has accelerated 
(Chiang, et al., 2012; Finelli, et al., 2007; Fruhmesser, et al., 2013; Fukushi, et al., 2018; 
Talkowski, et al., 2012). 
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Figure 1. Reciprocal balanced translocations (A), pericentric inversions (B), paracentric 
inversions (C) and insertions (D) are structural genomic variants commonly classified as 
balanced chromosomal aberrations. However, genes could be directly or indirectly affected 
by the breakpoints. 
 
A. RECIPROCAL TRANSLOCATION
B. PERICENTRIC INVERSION C. PARACENTRIC INVERSION
D. INSERTION
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1.2.2 Copy number variants   
Copy number variants (CNVs; deletions and duplications (Figure 2)) have been implicated in 
numerous diseases, but are also known to be present in healthy human genomes as benign 
polymorphic variants, present in >1% of individuals in different populations (Zhang, et al., 
2009a). Between 4.5%-9.5% of the genome has been estimated to contribute to copy number 
variation (Zarrei, et al., 2015) and it appears that as many as approximately 100 of the total 
protein-coding genes can be completely lost (homozygous deletion) without apparent 
phenotypic consequences (Zarrei, et al., 2015).  
Many disease-causing CNVs are large, involving several megabases of nucleotides, such as 
Prader-Willi syndrome/Angelman syndrome (MIM:176270/105830, 15q11-q13 deletion), 
Williams-Beuren syndrome (MIM:194050, 7q11.23 deletion) and Potocki-Lupski syndrome 
(MIM:610883, 17p11.2 duplication). However, small intragenic CNVs have with increased 
quality of detection methods been more commonly reported as contributors or independent 
drivers of disease (Lieden, et al., 2014; Lindstrand, et al., 2016).  
Conventional cytogenetic investigations mentioned in the introduction, such as karyotyping 
and FISH (fluorescent in situ hybridization) mapping, can only detect gain or loss of 
hundreds of kilobases (kb) (FISH) or megabases (Mb) (karyotyping) of nucleotides 
(Warburton, 1980). Today, for whole-genome investigation of copy number variation, 
chromosomal microarrays such as SNP arrays or comparative genomic hybridization arrays 
(aCGH) are the most commonly used methods. Regular aCGH platforms used in clinical 
practice, with evenly spread probes across the entire genome, commonly has a resolution of 
approximately 25-50 kb, depending on the number and distribution of probes. However, 
targeted arrays may increase the resolution down to a few hundred bases in specific target 
regions (Lindstrand, et al., 2016).  
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Figure 2. Copy number variants can be either deletions (A), where a piece of genetic 
material is completely lost, or duplications, where a piece of genetic material either has been 
duplicated in tandem (B), or inserted into another genomic position anywhere in the genome, 
sometimes in inverted orientation (C).  
 
1.2.3 Complex chromosomal rearrangements 
Complex chromosomal rearrangements (CCRs) involve a single or several chromosomes 
with three or more breakpoints as detected by chromosome analysis (Liu, et al., 2012). 
Complex genomic rearrangements (CGRs) are defined in the same way but also include 
submicroscopic rearrangements that are not seen on chromosome analysis but only detected 
using molecular tools, such as aCGH or WGS. Complex rearrangements of chromosomes 
have traditionally been detected using conventional cytogenetic methods such as karyotyping, 
FISH and aCGH. However, the poor resolution of these methods has made it difficult to fully 
A. DELETION
B. TANDEM DUPLICATION
C. INTERSPERSED DUPLICATION
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characterize the genomic complexities. Using WGS with paired or linked reads, a number of 
CCRs have now been solved down to nucleotide level and commonly, additional complexity 
is revealed by this high-resolution analysis (Aristidou, et al., 2018). More than half of de novo 
CCRs are associated with a clinical phenotype (Madan, et al., 1997), and as with regular 
CNVs the clinical symptoms may be caused by I) direct disruption of disease-associated  
genes in the breakpoints, II) deletions or duplications of dosage sensitive genes, or III) 
physical changes in the 3D structure of the genome (Hodge, et al., 2014; Lupianez, et al., 
2015; Lupianez, et al., 2016; Schluth-Bolard, et al., 2013; Talkowski, et al., 2012). Small 
(from 1 bp to a few kb) imbalances in the breakpoint junctions are generally only detected 
using sequencing techniques, which additionally can pinpoint the underlying mechanism of 
formation (see 1.4.3 Complex rearrangements). 
 
 
Figure 3. Complex chromosomal rearrangements can involve several chromosomes (A, 
interchromosomal) or a single chromosome (B, intrachromosomal). In example A, three 
chromosomes are involved in the rearrangement and during the reassembly segments B and 
D have been inverted. In example B, a single chromosome has been shattered and during 
reassembly, segments B, C, F and I have been lost, segment G has been inverted and 
segments H and J have been duplicated, with segment J also being inverted. 
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1.2.4 Structural variation of the non-coding human genome 
It has been known for a long time that long stretches of non-coding sequences, sometimes 
referred to as gene deserts, can contain regulatory elements important for gene expression. 
Although these regulatory elements can be located megabases away from the actual gene, a 
disruption of a seemingly harmless part of the genome was already in 2002 shown to be the 
cause of disease due to dysfunctional gene expression (Lettice, et al., 2002; Nobrega, et al., 
2003). The impact of structural variants on human disease was understood on a deeper level 
when position effects and the enhancer adoption concepts were reported, and new cases could 
be solved when the 3D structure of the genome was investigated (Lettice, et al., 2011). One 
of the proposed mechanisms to explain this phenomenon has been topologically associated 
domains (TADs). TADs are highly conserved genomic segments, megabases in size, which 
divide the genome into units with a high degree of intra-domain interaction, separated from 
one another by topological boundary regions, blocking the interaction between neighboring 
TADs. TADs are formed by chromatin loops, often involving “looping factors” such as the 
CCCTC-binding factor (CTCF) and cohesin, and contribute to the healthy genome by 
preventing faulty activation of genes. Structural variants, although cytogenetically balanced 
and not disrupting any coding sequences, may disrupt TADs and move enhancers, causing 
one or several genes to be up- or downregulated without actually interfering with the gene 
itself (Krijger and de Laat, 2016; Ordulu, et al., 2016; Redin, et al., 2017). As mentioned 
previously, seemingly balanced chromosomal rearrangements are more common in patients 
with various disease phenotypes. With this in mind, and the fact that more than 90% of BCA 
breakpoints are located in non-coding DNA, this is likely to be an important disease-causing 
mechanism (Krijger and de Laat, 2016; Lettice, et al., 2002; Maurano, et al., 2012; Nobrega, 
et al., 2003; Schaub, et al., 2012). 
 
1.3 WHOLE GENOME SEQUENCING FOR DETECTION OF STRUCTURAL 
GENOMIC VARIATION 
 
The 1000 Genomes Project started reporting structural variant data generated from aCGH, 
PCR and SNP arrays in 2010, focusing on CNVs (Mills, et al., 2011; Pennisi, 2010). In 2015, 
the first large report of structural variants from WGS data was published, which included 
inversions, mobile elements and very small SVs (<1 kb) (Sudmant, et al., 2015). In 
comparison to aCGH and FISH, WGS allows for simultaneous detection of single nucleotide 
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variants (SNVs), CNVs and BCAs. Since the introduction of massive parallel sequencing 
(MPS), the data has mostly been used to detect SNVs, and among the first MPS 
implementations were exome sequencing, exclusively used for SNV detection. Today, we 
know that WGS can detect most SVs, and provides detailed information such as position of 
segments, mutational signatures of junctions and exact location of breakpoints. The currently 
most commonly used human WGS protocol (Illumina Paired-End (PE) short-read WGS) 
provides the orientation of the two paired reads; an abnormal orientation may indicate an 
inversion, or in case of a duplication it shows if the extra segments is inserted or in tandem. 
Short insert sizes of PE WGS libraries often provide nucleotide resolution of breakpoints due 
to reads spanning the actual breakpoint, so called split reads (Mills, et al., 2011). The second 
most commonly used WGS protocol is Mate-Pair (MP) sequencing and PE and MP WGS 
protocols are very similar but works optimally for different types of SVs. In PE WGS, short 
fragments (300-800 bp) of DNA are sequenced while MP libraries use longer DNA 
fragments (1,000-4,000bp) that are first circularized, the sequence pairs are therefore oriented 
in inverse orientation and are generally further apart than in PE libraries. Generated reads for 
both methods are commonly 100-150 base pairs in length. The raw WGS data is aligned to 
the human reference genome, and many different bioinformatics tools are used to identify and 
annotate variants. Detection of SVs from either PE or MP sequencing libraries is based on 
read depth, discordant sequence pairs mapped to unexpected places or directions (Fullwood, 
et al., 2009) and de novo assembly. Examples of callers for structural variant detection are 
CNVnator (Abyzov, et al., 2011), Manta (Chen, et al., 2016), and TIDDIT (Eisfeldt, et al., 
2017).  
A limitation for precise mapping of breakpoint junctions are low copy repeats (LCRs), 
common in recurrent structural variants, and regular short-read libraries such as PE and MP 
will often not sufficiently cover the entire repeat. For these variants, other sequencing 
methods have been developed, commonly referred to as third-generation sequencing or long-
read sequencing; PacBio (Pacific Biosciences) and Nanopore (Oxford Nanopore 
Technologies) are examples of third-generation sequencing technologies. Other technologies 
utilize barcoded reads to synthesize long reads bioinformatically (10X Genomics Chromium) 
or optical maps to generate low-resolution maps of the genome (Bionano Genomics). PacBio 
sequencing captures sequence information during the replication process of a single molecule 
and generates reads around 10 kb in length (Rhoads and Au, 2015) while Nanopore 
sequencing generates sequence information by having single DNA strands passing through a 
biological pore and generates an output of 10-100 kb reads, depending on the fragment sizes 
of the input DNA (Lu, et al., 2016). Linked-read sequencing provided by 10X Genomics 
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Chromium protocol utilizes long DNA molecules that are barcoded and separated into 
droplets, and sequenced barcodes links the sequences that belong to the same long DNA 
molecule (Eisfeldt, et al., 2019). Bionano is not a sequencing technique but instead uses 
fluorescently tagged probes to image the genome and reveal structural changes but no 
sequence variation (English, et al., 2015).      
 
1.4 STRUCTURAL VARIANT MECHANISMS OF FORMATION 
 
1.4.1 Recombination mechanisms 
Mutational signatures in the breakpoint junctions of genomic rearrangements may provide 
insight into the mechanism involved in the original rearrangement formation (Figure 4). For 
example, the presence of large segments of homologous DNA (>200 bp) flanking the 
junction would imply non-allelic homologous recombination (NAHR) as the chromosome 
break and repair mechanism (Stankiewicz and Lupski, 2002; Waldman and Liskay, 1988).  
 
Figure 4. Mutational signatures in breakpoint junctions provide clues on the underlying 
mechanism of formation. NHEJ; non-homologous end-joining, FoSTeS; fork-stalling and 
template-switching, SINE; short interspersed nuclear element, LINE; long interspersed 
nuclear element, SD; segmental duplication, NAHR; non-allelic homologous recombination, 
MMBIR; microhomology-mediated break-induced replication 
A B
jct
chrA ACCTGATGCCCTTGACTGTGACGTAGGGAACTGGTCAGAGTCGATCGATCGTTGAT
jct ACCTGATGCCCTTGACTGTGACGTAGGGACCTGATCGATCGATGGGATGCGGCATG
chrB GCTTGATCGATGGCTATAGCTAGCTTAGCCCTGATCGATCGATGGGATGCGGCATG
chrA ACCTGATGCCCTTGACTGTGACGTAG......GATCAGAGTCGATCGATCGTTGAT
jct ACCTGATGCCCTTGACTGTGACGTAG......GATCGATCGATGGGATGCGGCATG
chrB GCTTGATCGATGGCTATAGCTAGTAG......GATCGATCGATGGGATGCGGCATG
chrA ACCTGATGCCCTTGACTGTGACGTAGGGAACTGGTCAGAGTCGATCGATCGTTGAT
jct ACCTGATGCCCTTGACTGTGACGGCCTGACCTAGCCTGATCGATCGATGGGATGCG
chrB GCGTTGCTTGATCGATGGCTATAGCTAGCTTAGCCCTGATCGATCGATGGGATGCG
chrA ACCTGATGCCCTTGACTGTGACGTAGGGAACTGGTCAGAGTCGATCGATCGTTGAT
jct ACCTGATGCCCTTGACTGTGACGTAGGGACCTGATCGATCGATGGGATGCGGCATG
chrB GCTTGATCGATGGCTATAGCTAGCAGGGACCTGATCGATCGATGGGATGCGGCATG
Blunt ends:
NHEJ, FoSTeS
Homology:
NAHR
Insertion:
NHEJ (random nucleotides)
FoSTeS/MMBIR (templated)
Microhomology:
NHEJ, FoSTeS/MMBIR
Repetitive element (SINE, LINE, SD)
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Several lines of evidence show that sequences with repetitive features are targets for NAHR, 
and are hence prone to cause recurrent balanced and unbalanced genomic rearrangements 
(Liu, et al., 2012). In recurrent structural variants, the breakpoints cluster in the same 
genomic intervals and the resulting aberration is similar in size and position between carriers 
(Liu, et al., 2012). NAHR was the first mechanism identified to be involved in chromosomal 
rearrangement formation. NAHR is also the mechanism responsible for genomic disorders 
(Lupski, 1998) where unequal crossing over between highly similar genomic segments on 
homologous chromosomes (i.e. LCRs or segmental duplications) in direct orientation result 
in deletions and duplications (Figure 5). Inverted repeats may result in inversions and 
crossing-over between LCRs in non-homologous chromosomes can produce recurrent 
translocations (Ou, et al., 2011). It has been proposed that 300-500 bp of perfectly matching 
DNA sequence is the minimal efficient processing segment for NAHR to occur (Reiter, et al., 
1998).  
 
 
 
Figure 5. Non-allelic homologous recombination (NAHR) can occur when low copy repeats 
(LCRs) on homologous chromosomes recombine due to sequence similarity. Some parts of 
the genome are more prone to NAHR-mediated rearrangements due to high LCR content in 
those areas. Recurrent structural variants are formed through NAHR.  
 
B CA
B CALCR LCR LCR
LCR LCR LCR
Crossing-over
B CALCR LCR LCR
B CLCR LCR
A LCR
Segment A deleted
Segment A duplicated
  14 
1.4.2 Replication mechanisms 
Replication-based mechanisms (RBMs) such as fork stalling and template 
switching/microhomology mediated break-induced replication (FoSTeS/MMBIR) have been 
proposed as the underlying mechanism of formation of complex and non-recurrent structural 
variants in humans (Lee, et al., 2007; Zhang, et al., 2009b). Mutational signatures implying 
RBM-mediated rearrangements include presence of microhomology, small templated 
insertions and novel SNVs in close proximity of the breakpoint junction and 
duplications/triplications accompanying large inverted genomic segments (Carvalho, et al., 
2011). 
In Pelizaeus-Merzbacher disease (MIM:312080), caused by non-recurrent duplications or 
deletions of proteolipid protein 1 (PLP1), high-resolution aCGH and subsequent breakpoint 
sequence analyses have revealed interspersed stretches of DNA within the duplicated 
sequence and sequence complexity at the junctions (Lee, et al., 2007). These findings 
suggested that mechanisms involving errors of DNA replication, rather than the generally 
considered meiotic recombination mechanisms, could cause structural genomic 
rearrangements. Briefly, the FoSTeS model proposed was that during DNA replication, the 
active replication fork stalls and switches template using complementary template 
microhomology to prime re-annealing. The process may involve forks linearly far apart in the 
genome but in close 3D proximity (Lee, et al., 2007). 
 
1.4.3 Complex rearrangements 
Whole-genome sequencing studies have identified many CGRs that appear to be derived 
from a single catastrophic event, sometimes referred to as “chromosome pulverization” and 
what appears to be a random reassembly of the chromosome fragments. Two separate 
complex catastrophic phenomena are often described in congenital chromosomal 
rearrangements: chromothripsis and chromoanasynthesis (Liu, et al., 2011; Masset, et al., 
2016).  
Chromothripsis has been proposed to originate in a multi-step process, where chromosome 
segregation errors first result in formation of micronuclei, and chromosomes trapped within 
the micronuclei undergo delayed DNA replication and become fragmented. In the next cell 
cycle, the damaged chromatin undergoes complex rearrangements and subsequent fusion of 
the micronucleus with the main nucleus results in a daughter cell carrying a highly rearranged 
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chromosome. The proposed mechanism for the repair process is non-homologous end-joining 
(NHEJ) (Kloosterman, et al., 2012; Zhang, et al., 2015). The concept of micronuclei would 
explain the mystery of how such catastrophic cellular events could be isolated to relatively 
small parts of the genome. Although first described in cancer cells, chromothripsis is also a 
likely involved in germline complex de novo structural rearrangements (Kloosterman, et al., 
2011). 
Chromoanasynthesis is mediated by replications errors (Lee, et al., 2007). The first report on 
chromoanasynthesis came in 2011 when Liu et al. investigated patients with developmental 
anomalies and discovered several duplications, triplications and deletions, and subsequent 
sequencing of the breakpoint junctions revealed microhomology and templated insertions, 
consistent with FoSTeS/MMBIR (see 1.3.2 Replication mechanisms) (Liu, et al., 2011). A 
distinct form of chromoanasynthesis, referred to as atypical chromoanagenesis, was first 
reported in 2016 by Masset et al., who reported complex rearrangements containing only 
copy number gains (Masset, et al., 2016). The chromosomal aberrations were reported to only 
affect a single chromosome, and being dispersed throughout the entire chromosome. The 
main difference from the other type of chromoanasynthesis was the presence of duplications 
only and up to 40 bp of non-templated insertions in the breakpoint junctions, and the 
proposed joining mechanism was DNA polymerase Polθ-driven alternative NHEJ (Masset, et 
al., 2016).  
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2 AIM OF THESIS 
 
The overall purpose of this thesis was I) to characterize human chromosomal aberrations such 
as CNVs, translocations, inversions, and complex rearrangements, in order to elucidate 
possible mechanisms of formation as well as mechanisms of disease, and II) improve the 
diagnostic methods for SV detection. We have performed detailed studies of rare 
chromosomal aberrations, in hope of identifying disease-causing genetic alterations.  
By using whole genome sequencing, we have a unique opportunity to identify and 
characterize the breakpoints of structural variants with nucleotide resolution, which is 
essential for deeper understanding of the underlying mechanisms of formation, as well as 
pinpointing of specific genes in or in close proximity of the breakpoint(s).  
Specifically, the aims of this thesis were to: 
I. Pinpoint and characterize breakpoint junctions of structural variants at the nucleotide level 
II. Use mutational signatures to elucidate possible mechanisms of formation 
III. Identify known or novel disease genes in or in close proximity of the breakpoints 
IV. Identify the cellular process that caused the chromosomal aberration to occur 
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3 MATERIAL AND METHODS 
3.1 PATIENTS AND CLINICAL DATA 
All patients included in paper I were collected at the Clinical Genetics department, 
Karolinska University Hospital (Stockholm, Sweden), or in one case at Helsinki University 
Hospital (Helsinki, Finland). The study covered 22 individuals, in which conventional 
chromosome analysis had identified at least one cytogenetically balanced translocation (one 
patient was a carrier of two separate translocations). Twelve of the patients had been referred 
for chromosome analysis because of an affected phenotype and ten had first been referred for 
amniocentesis because of age, worry, ultrasound findings, multiple previous miscarriages, or 
previous birth of a child with an unbalanced karyotype. Eight of these individuals were 
unaffected, and two had mild neurodevelopmental disorders.  
Both patients in paper II were first identified at the Clinical Genetics department, Karolinska 
University Hospital (Stockholm, Sweden) and were originally referred for genetic 
investigation because of clinically affected phenotypes (skeletal dysplasia).  
The proband in paper III was referred to the Clinical Genetics department, Karolinska 
University Hospital (Stockholm, Sweden) due to clinically affected phenotype presenting 
within the first year of life. Clinical aCGH revealed a large duplication and segregation 
analysis of the parents revealed that the mother carried two small deletions, flanking the area 
that was duplicated in the proband, which prompted for further analysis in a research setting. 
All patients included in paper IV were collected at the Clinical Genetics department, 
Karolinska University Hospital (Stockholm, Sweden), Linköping University Hospital 
(Linköping, Sweden), Sahlgrenska University Hospital (Gothenburg, Sweden), Baylor 
College of Medicine (Houston, Texas, USA) and University of São Paolo (São Paolo, Brazil). 
A total of 24 patients were included, carrying 16 unique cytogenetically visible inversions (13 
pericentric and three paracentric). All patients had originally been referred for chromosomal 
analysis due to a clinically affected phenotype, fertility problems or a clinically affected 
child/intrauterine fetal death. 
In paper V, we reported 21 individuals with clustered CNVs. Out of the 21 included 
individuals, five had been collected at the Kennedy Center (Rigshospitalet, Copenhagen, 
Denmark), two at Sahlgrenska University Hospital (Gothenburg, Sweden), one at Linköping 
University Hospital (Linköping, Sweden) and 13 at the Karolinska University Hospital 
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(Stockholm, Sweden). All included cases had been referred to each medical center for genetic 
investigation using aCGH due to congenital developmental disorders, intellectual disability or 
autism.  
 
3.2 MOLECULAR ANALYSES 
3.2.1 Cytogenetic analyses 
3.2.1.1 Karyotyping 
Metaphase slides were prepared from peripheral blood cultures, according to standard 
protocols. Chromosome analysis (Figure 6) was performed after G-banding with an 
approximate resolution of 550 bands per haploid genome. At least 10 metaphases were 
analyzed for each patient. 
 
Figure 6. Karyotype visualizing a complex chromosomal rearrangement involving 
chromosome 1, chromosome 5 and chromosome 10 (46,XY,t(1;10;5)(q32;p12;q31). Larger 
chromosomal rearrangements involving pieces >10 Mb can be visualized using traditional 
G-banding chromosome analysis. The patient is reported in (Lindstrand, et al., 2010) and 
(Eisfeldt, et al., 2019). 
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3.2.1.2 Array comparative genomic hybridization (aCGH) 
The aCGH studies were performed using three different microarray designs: I) a clinically 
used 180K design with 180,000 probes evenly covering the genome, II) a 1M medical exome 
array with 1,000,000 probes targeting 6,000 known disease-associated genes, and III) a 
custom design, designed using eArray, an online web tool from Agilent Technologies (Palo 
Alto, CA, USA). The custom design was an Agilent 2x400K high-definition comparative 
genomic hybridization microarray design (Agilent Technologies), consisting of 400,000 
oligonucleotide probes. Out of the 400,000 probes, approximately 180,000 probes evenly 
covered the genome with a resolution of approximately 25-50 kb. Remaining probes targeted 
1989 genes found in the cilia proteome and/or involved in malformation syndromes and 
intellectual disability. The resolution within targeted genes was 1 probe per 100 bp in coding 
sequences, and 1 probe per 500 bp in noncoding sequences. The array slides used for the 
experiments were ordered from Oxford Gene Technology (OGT, Oxfordshire, UK).  
 
Figure 7. Array 
comparative genomic 
hybridization (aCGH) 
data visualized in 
CytoSure Interpret 
Software. A large 
duplication was identified 
in a patient with 
developmental delay (A), 
and two small deletions 
flanking the duplication 
were found in the mother 
(B). Figure adapted and 
modified from paper III. 
 
A
B
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3.2.2 Whole genome sequencing 
3.2.2.1 30X PCR-free paired-end sequencing protocol 
In paper II, paper III, paper IV and paper V, samples were subjected to WGS using a 30X 
PCR-free PE WGS protocol at National Genomics Infrastructure (NGI), Science for Life 
Laboratory, Stockholm, Sweden. PE-WGS protocols generate short (2x150 bp) paired reads, 
suitable for detection of SVs through both discordant read pairs and aberrant read depth. Data 
was processed using the NGI-piper and SVs were detected and analyzed using the in-house 
FindSV pipeline (https://github.com/J35P312/FindSV) that combines CNVnator V0.3.2 
(Abyzov, et al., 2011) and TIDDIT (Eisfeldt, et al., 2017) and generates a single variant call 
format (VCF) file. The VCF file was annotated using variant effect predictor (VEP) and 
filtered based on the VCF file quality flag (McLaren, et al., 2016). Finally, the VCF file was 
sorted based on a local structural variant frequency database consisting of 351 patient 
samples. Split reads were identified when visualizing the breakpoint regions of each variant 
in IGV (http://software.broadinstitute.org/software/igv/) (Robinson, et al., 2011) and the 
exact position of the breakpoints could be determined in most cases using the BLAT 
(https://genome.ucsc.edu/cgi-bin/hgBlat) (Kent, 2002).   
3.2.2.2 3X 2.5kb insert-size mate-pair sequencing protocol 
In paper I and paper V, we used a low-coverage (3X) MP sequencing protocol at NGI, 
Science for Life Laboratory, Stockholm, Sweden, generating short (2x100 bp) paired reads. 
Raw sequences were base called using CASAVA RTA 1.18 
(http://support.illumina.com/sequencing/sequencing_software/casava.htm) followed by 
removal of adapter sequences using Trimmomatic (Bolger, et al., 2014). Remaining read 
pairs were aligned to the Hg19 human reference genome using BWA (Li and Durbin, 2009) 
and discordant read mapping was called using TIDDIT (Eisfeldt, et al., 2017) as described in 
the previous section (3.2.2.1 30X PCR-free paired-end sequencing).  
3.2.2.3 Linked-read sequencing 
Linked-read sequencing was performed on two samples in paper IV and one sample in 
paper V, using 10X Genomics Chromium WGS protocol at NGI, Science for Life 
Laboratory, Stockholm, Sweden. Input DNA is kept as intact as possible to allow for linked 
reads spanning large genomic areas, and the long DNA fragments are referred to as 
molecules. Molecules are separated into oil droplets and a unique barcode is attached to the 
DNA in multiple in each droplet, followed by fragmentation of molecules into ~300 bp 
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fragments before sequencing on an Illumina sequencer. The linking of tagged reads is 
performed after sequencing, when each barcode is matched together with other reads 
containing the same barcode, hence belonging to the same original DNA molecule. The 
library was prepared using the 10X Chromium controller and sequencing was performed on 
an Illumina HiSeq Xten platform. Resulting data was analyzed using 10X Genomics-
provided pipelines called Long Ranger and Supernova de novo assembler.  
3.2.2.4 Validation of WGS results 
All breakpoints where breakpoint junctions could be precisely mapped were confirmed with 
PCR and Sanger sequencing. Breakpoint PCR was performed using Phusion High-Fidelity 
DNA Polymerase (ThermoFisher Scientific) and sequenced using standard Sanger 
sequencing protocols. Sequences were aligned using BLAT (UCSC Genome Browser) (Kent, 
2002) and visualized in CodonCode Aligner (CodonCode Corp., Dedham, MA, USA) 
(Figure 8). All cryptic CNVs in the breakpoints were confirmed using aCGH with the same 
protocols as described in section 3.2.1.2 Array comparative genomic hybridization (aCGH). 
 
Figure 8. Sanger traces visualized in CodonCode Aligner software. Above example is a 
balanced translocation between chromosomes 17 and X, with a 5 nt microhomology in the 
der(17) breakpoint junction (purple box) and a 12 nt insertion in the der(X) breakpoint 
junction (pink dotted line box). Picture is adapted from Paper I.  
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3.2.3 Zebrafish studies 
Functional studies in model organisms are crucial for correct interpretation of variants in 
novel disease genes or novel types of variants in known disease genes. Many genes are 
conserved across species, enabling in vivo studies of the pathophysiology of genetic 
aberrations in humans. Humans share over 98% of the genomic sequence with chimpanzee 
(Pan troglodytes) (Chimpanzee and Analysis, 2005), ~92% with mouse (Mus musculus) 
(Mouse Genome Sequencing, et al., 2002) and ~70% with zebrafish (Danio rerio) (Howe, et 
al., 2013). Zebrafish is a very popular model organism for early developmental studies, 
mainly because the fertilization and development occur ex utero. In addition, the fertilized 
eggs are transparent during the first week of development and therefore embryogenesis can 
easily be monitored. The majority of organs and tissues in humans are also present in 
zebrafish, for example vascular system, liver, brain and skeletal/cartilage tissues (Hammarsjo, 
et al., 2017; Hofmeister, et al., 2015; Hofmeister, et al., 2018; Laurell, et al., 2014; Song, et 
al., 2016; Wilkinson, et al., 2014). For quick screening of the impact of gene variants in the 
zebrafish model, gene expression can be easily modulated using knockdown or 
overexpression techniques. Injection of antisense oligonucleotides (morpholinos) results in 
gene knockdown, and injection of human mRNA (wild-type or with genetic variants found in 
patients) into the newly fertilized zebrafish eggs results in gene overexpression. The 
discovery of gene editing tools such as the CRISPR/Cas9 (and similar techniques developed 
in the previous years) and their application in model organisms has revolutionized the way 
researchers assess variants found in patients. This technique allows for stable mutagenesis of 
the study model carrying specific variants of interest, and mutations are passed on through the 
germline (Albadri, et al., 2017; Li, et al., 2016). 
In paper II, we used a zebrafish model to assess the clinical impact of an intragenic IFT81 
duplication. The patient presented with less severe clinical symptoms than previously 
published cases with loss of IFT81 protein, and Western blot analysis suggested that a shorter 
isoform of the transcript was unaffected by the duplication. Hence, we wanted to test whether 
a truncated transcript of human IFT81 could rescue the phenotype of an ift81 knockdown. For 
this, we used morpholino knockdown to reduce endogenous ift81 expression in combination 
with overexpression of human wildtype (wt) and truncated IFT81 mRNA. Adult zebrafish 
were maintained on a 14 h day/10 h night cycle at Karolinska Institutet zebrafish core facility 
and embryos were produced by mass spawning. Injection of morpholinos and mRNA was 
performed at the 1-cell stage and embryos were maintained at 25°C until phenotype 
assessment at the 8-10 somite stage (~12-14 hours post fertilization).  
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4 RESULTS AND DISCUSSION 
 
4.1 PAPER I  
 
In paper I, we characterized 23 cytogenetically balanced translocations using low-coverage 
(3X) MP WGS and subsequent Sanger sequencing, hypothesizing that reciprocal 
translocations may be mediated by other mechanisms than non-homologous end-joining 
(NHEJ) or non-allelic homologous recombination (NAHR). In total, 46 breakpoint junctions 
from 22 carriers (one individual carried two separate reciprocal translocations) were 
characterized. Out of the total number of included cases, eight were reported clinically 
unaffected (36.4%) and 14 had an affected phenotype (63.6%).  
Analysis of the breakpoint junctions revealed that protein-coding genes were disrupted in 
48% of the breakpoints, and to the same extent in the clinically unaffected cohort as in the 
clinically affected cohort. However, in the clinically unaffected cohort the disrupted known 
disease genes were all recessive (COG7, ALMS1, LARGE, OCA2), and in the clinically 
affected cohort we identified three disrupted known dominant intellectual disability genes 
(CTNND2, EXOC6B, GRIN2B). Hence, three individuals received a molecular genetic 
diagnosis as a result of the study. It is also important to note that the four clinically unaffected 
carriers are heterozygous carriers of that recessive disease, in addition to being more prone to 
have fertility problems due to malsegregation of the rearranged chromosomes. 
Five candidate genes for neurocognitive disabilities were identified (SVOPL, SUSD1, TOX, 
NCALD, SLC4A10), as well as two candidate genes for Tourette syndrome/tics (LYPD6, 
GPC5). In addition, a de novo 11.4 Mb deletion on chromosome 1p31, affecting 37 protein-
coding genes and classified as pathogenic, was found in one individual. 
Finally, detailed characterization of the 46 breakpoint junctions revealed typical mutational 
signatures of replication-based repair mechanisms such as FoSTeS/MMBIR in a substantial 
fraction of the translocations (17.4%, n=4). Such mutational signatures are typically 
microhomology and templated insertions, as well as rare SNVs in close proximity of the 
junction(s) (Figure 9). The findings indicated that FoSTeS/MMBIR is likely to be responsible 
for the formation of balanced reciprocal translocations to a larger extent than previously 
reported, possibly as high as 17% of interchromosomal translocation events.  
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Figure 9. Example of a reciprocal cytogenetically balanced translocation from paper I with 
mutational signatures of replication based repair mechanisms in the junctions of der22.  
 
None of the reported junctions were mediated by LCRs or other repeat elements. One 
translocation had both breakpoints within Alu elements but only a very short microhomology 
of 3 nt was present in both breakpoint junctions, indicating that no fusion Alu element was 
formed. However, a 1,579 bp deletion present 121 bp upstream of the breakpoint junction of 
one derivative chromosome was identified, generating a fusion Alu (AluSx3-AluY). These 
findings are consistent with a template-switching event, causing both the small deletion and 
the reciprocal translocation (Figure 10). 
 
 
Figure 10.  Schematic overview of 5q14.1 and 7q34 regions. The derivative chromosome 5 
(der5) is shown in blue and derivative chromosome 7 (der7) is shown in green. Alu elements 
are shown as dark grey boxes. The small deletion upstream of the breakpoint junction on 
der5 is shown as a dashed blue line. Both deletion breakpoints as well as the reciprocal 
translocation breakpoints are located within Alu elements. The figure is adapted and 
modified from paper I. TS; template-switching 
chr16(23411369+)GCTAGGAGTGGATCATGGTTGGAGCAGGTGATGAGTATATGGAGttccTTATAC------TCTTCTCCCTACTTCTGTGTATGCGTGAAAAGGTCCATAAGAAGTT
                                                                ||||||      ||||||||||||||||||||||||||||||||||||||||||||||
der22           CAAAACAAAACAAAAACAAAAACAAAAGAAAACAAAAAAACTATGCAATTATACTTATACTCTTCTCCCTACTTCTGTGTATGCGTGAAAAGGTCCATAAGAAGTT
                ||||||||||||||||||||||||||||||||||||||||||||||||||| 
chr22(44818112-)CAAAACAAAACAAAAACAAAAACAAAAGAAAACAAAAAAACTATGCAAttaaaTTAAGTGCACGAGGCAACTCCTTGGAAGCAGTGGGCAGCAGGCAGTGCAAGAC
         
chr16(23411366+)AACAGGATGGCTAGGAGTGGATCATGGTTGGAGCAGGTGATGAGTATATGGAGttccTTATACTCTTCTCCCTACTTCTGTGTATGCGTGAAAAGGTCCATAAGAA
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||
der16           AACAGGATGGCTAGGAGTGGATCATGGTTGGAGCAGGTGATGAGTATATGGAGTTAAGTGCACGAGGCAACTCCTTGGAAGCAGTGGGCAGCAGGCAGTGCAAGAC
                                                                     |||||||||||||||||||||||||||||||||||||||||||||||||||||
chr22(44818112-)CAAAACAAAACAAAAACAAAAACAAAAGAAAACAAAAAAACTATGCAAttaaaTTAAGTGCACGAGGCAACTCCTTGGAAGCAGTGGGCAGCAGGCAGTGCAAGAC
GA
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AT
A TATACTC
:::::::
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AluJo AluSx3 AluJo AluSq2 AluY
der5 der5 der7
der7 der5
AluSz6
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4.2 PAPER II 
 
In paper II, we first performed targeted CNV screening in two individuals with distinct 
skeletal dysplasias (Patient 1: Jeune syndrome (MIM:208500), Patient 2: multiple epiphyseal 
dysplasia (MED) type 5 (MIM:607078)) and identified intragenic, exonic duplications in 
IFT81 (Patient 1) and MATN3 (Patient 2).  
Both patients had previously been investigated with exome sequencing with a negative result. 
To assess whether small or large CNVs could explain the clinical phenotype, a customized 
aCGH was used targeting 1,989 genes previously implicated in ciliopathies, skeletal 
dysplasias, intellectual disability and congenital malformation syndromes. The custom aCGH 
analysis identified intragenic duplications in IFT81 (12.4 kb) and MATN3 (10.4 kb). The 
practical resolution of the regular clinical aCGH used at the Karolinska University Hospital is 
25-50 kb, and both duplications would hence have been missed without the custom aCGH 
design. Both IFT81 and MATN3 had previously been implicated in skeletal dysplasias 
(IFT81; Jeune syndrome, MATN3; multiple epiphyseal dysplasia type V) concordant with the 
phenotypes of the included individuals.  
Follow-up studies with short-read WGS and breakpoint PCR showed that both duplications 
were in tandem orientation and most likely disrupted the open reading frame (ORF) of the 
canonical transcript of both genes (Figure 11). In addition, we discovered that the duplication 
in IFT81 was present in four copies (homozygous) and segregation analysis of the healthy, 
non-related parents revealed that both were heterozygous carriers of the rare duplication. 
Figure 11.  Intragenic 
duplications predicted to cause 
disruption of open reading 
frames and truncated proteins 
in both patients. Both 
duplications were predicted to 
cause truncated proteins of both 
IFT81 and MATN3, possibly 
leading to nonsense-mediated 
decay. Picture adapted and 
modified from paper II. 
IFT81 80kDa
IFT81 50kDa
Patient 1 IFT81 
Wild-type MATN3
Patient 2 MATN3
0
0
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amino acids
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348
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Hypothesizing that the parents of Patient 1, heterozygous for the same rare duplication in 
IFT81, shared a common ancestor we performed a loss of heterozygosity (LOH) analysis of 
the WGS data in the patient. The results showed that three small regions of the patient’s 
genome showed LOH. One of the regions was a 4.8 Mb region on chromosome 12, which 
included the IFT81 locus. The regions displaying LOH were however so small that the 
sample from Patient 1 clustered with the known non-related samples in a follow-up analysis 
(Figure 12). 
 
Figure 12. Analysis of loss of heterozygosity (LOH) in 14 samples. WGS data from Patient 
1 carrying the homozygous IFT81 duplication was analyzed for LOH and compared to four 
known consanguineous samples and nine known unrelated samples. It was found that Patient 
1 (black) clustered with the unrelated samples, indicating that the common ancestor of the 
parents is several generations back. Figure adapted from paper II. RHO; regions of 
homozygosity 
Western blot analysis with protein extracted from fibroblasts from Patient 1 did not detect 
any wild-type full-length IFT81 protein (80 kDa), but only a shorter IFT81 isoform (50 kDa) 
that was also present in the healthy control fibroblasts. Complementary zebrafish studies 
suggested that even though the duplication results in loss of the full-length IFT81, remaining 
expression of a shorter IFT81 isoform is able to partially compensate the function of the full-
length isoform, resulting in the milder form of Jeune syndrome seen in Patient 1.  
Finally, split reads from the WGS data and breakpoint PCR showed that both duplications 
likely were Alu-Alu mediated with both breakpoints located within Alu elements and high 
sequence homology in the junctions. 
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4.3 PAPER III 
 
In paper III, the proband was referred for genetic investigation due to developmental delay 
and mildly dysmorphic facial features and clinical aCGH identified a large duplication of 
approximately 1 Mb at chromosome 5p13. The duplication involved the NIPBL gene and 
duplications overlapping this specific locus cause the 5p13 duplication syndrome 
(MIM:613174).  
During segregation analysis of the duplication it was found that the healthy mother carried 
two small deletions, flanking the region that was duplicated in the proband, which prompted 
for further analysis with WGS. It was found that in fact, the mother carried a total of five 
distinct deletions, sized between 20 kb and 100 kb, of which four were part of a chromosomal 
rearrangement with characteristics suggesting chromothripsis. In addition to the two small 
deletions flanking the duplication found in the proband a third deletion, sized only 20 kb and 
not detectable with regular aCGH (resolution ~50 kb), was present. Furthermore, the large 
duplication first identified in the proband was in fact two duplications of approximately 500 
kb each. Finally, resolving the structure of the chromothriptic chromosome in the mother also 
revealed the origin of the disease-causing rearrangement in the proband; the derivative 
chromosome harboring the NIPL duplication had formed through unequal crossing-over 
during meiosis (Figure 13).  
Figure 13. Unequal crossing-over 
during meiosis of a benign 
derivative chromosome 5 causes 
pathogenic duplications. The benign 
derivative chromosome 5 in the 
mother, missing segments B, D, F 
and H (A) produced two unbalanced 
gametes (B), where gamete II had 
rescued all deletions except segment 
B and gained extra copies of 
segments E and G. Fertilization of 
gamete II with the paternal normal 
chromosome 5 caused duplications 
of segments E and G (C). 
Figure adapted and modified from 
paper III. 
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4.4 PAPER IV 
 
In paper IV we aimed to characterize 16 unique (24 in total) cytogenetically detected 
chromosomal inversions in detail, in order to investigate the mechanism of formation and 
genotype-phenotype correlations in the clinically affected individuals. Out of the total of 16 
unique inversions, we were able to characterize 11 (69%) at the nucleotide level. Among 
these 11 inversions, we found that two seemingly recurrent inversions actually were identical 
by descent with identical breakpoint junctions showing little to no microhomology. To 
further analyze those two inversions, we performed haplotype analysis on the WGS data, 
hypothesizing that the carriers would share haplotypes on the affected chromosomes 
(chromosome 10 and chromosome 12, respectively). The analysis showed that all individuals 
carrying the same inversion (inv(10)(p11.2q13) or inv(12)(p11.2q21)) shared both common 
and more rare haplotypes compared to 13 unrelated individuals of Swedish descent (p-values 
2.8e-07 for inv(10) and 1.8e-08 for inv(12)). 
Next, we found that two of the studied inversions were not copy number neutral; one, 
inv(X)(p22.31q28), had duplications flanking the inversion (DUP-INV-DUP) (Figure 14), 
and the other, inv(12)(q11.2q24.1) (Figure 15), involved both duplications and a deletion 
(DUP-INV-DEL-DUP) in addition to the inverted segment. Both of these complex inversions 
showed mutational signatures in the breakpoint junctions consistent with MMBIR, and the 
inv(X) was mediated by Alu elements. 
 
 
Figure 14. A seemingly balanced inversion on chromosome X showed additional 
complexity in both breakpoints. The inversion had been mediated by Alu elements, and the 
duplications had been formed concomitantly to the inversion. The distal breakpoints made 
the inversion prone to produce unbalanced gametes and segregation studies of the family 
identified two unbalanced recombinant chromosomes (rec(X)), with deletion of segment A 
(9.4 Mb) and duplications of segments D (58 kb) and E (1.8 Mb).  
A B C E
A B C
chr(X)
inv(X)
Erec(X)
B
D
D ED
BD ED C
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Phasing the complex inv(X) rearrangement with WGS data from linked-read sequencing 
(10X Genomics Chromium) showed that both duplications originated from the same allele as 
the inversion and hence had been formed concomitantly with the inversion. The inversion and 
both duplications were mediated by Alu elements and fusion Alus were formed in both 
inversion breakpoint junctions. The breakpoints on Xq28 involved the Opsin gene/TEX28 
region that previously has been implicated in the formation of MECP2 duplications and 
hence is known to be prone to rearrangements (Carvalho, et al., 2009). Finally, the family 
segregation studies revealed that two individuals in the family from two generations had 
unbalanced recombinant chromosomes resulting from inv(X): one adult female presenting 
with typical skeletal manifestations consistent with SHOX deletions and Leri-Weill 
dyschondrosteosis (MIM:127300), and one male with severe malformations who died in 
utero. 
The inversion on chromosome 12 involved a small deletion (3.8 kb) and two small 
duplications (7.9 kb and 25 kb, originating from 12p and 12q, respectively). The final 
structure of the chromosome was predicted using the WGS data and confirmed using droplet 
digital PCR, showing that the B-E junction was indeed present twice. No genes were however 
affected by either of the CNVs or the inversion breakpoints.  
 
Figure 15. A seemingly balanced pericentric inversion on chromosome 12 had small 
imbalances in the breakpoints. The predicted structure was determined by the WGS data and 
digital droplet PCR further confirmed that the B-E junction was indeed present twice. Figure 
is adapted and modified from paper IV. 
In conclusion, none of the inversions that were resolved at the nucleotide level (11/16, 69%) 
were mediated by ectopic recombination between inverted repeats, but instead most of the 
breakpoint junctions were simple and consistent with formation mechanisms commonly 
associated with reciprocal translocations, such as NHEJ. Two of the seemingly balanced 
inversions were not copy number neutral and showed mutational signatures consistent with 
replication errors and MMBIR. Finally, we showed that high-coverage short-read WGS 
detects a substantial fraction of chromosomal inversions with nucleotide resolution. 
chr12
inv(12)
A B CB D E F
A C FB BE E
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4.5 PAPER V 
 
In paper V, we performed WGS on 21 individuals carrying multiple CNVs on the same 
chromosome arm aiming to characterize the breakpoint junctions (BPJs) in detail and 
delineate the structure of the rearranged chromosomes. A total of 83 BPJs were identified and 
all rearrangements were classified according to the patterns observed: deletions-only (n = 8), 
duplications-only (n = 7) and deletions-and-duplications (n = 6). In the deletions-only group, 
we observed additional structural rearrangements and BPJ characteristics typical to 
chromothripsis, while the duplications-only and deletions-and-duplications groups 
demonstrated mostly interspersed duplications and BPJs with microhomology. Two 
rearrangements were repetitive element-mediated (Alu and LINE, respectively) (Figure 17), 
and two rearrangements were found to be identical (2p25.3 clustered CNVs) at nucleotide 
level. 
Detailed characterization of the rearranged chromosomes revealed that multiple cellular 
mechanisms are likely to be involved in the formation of clustered CNVs, such as breakage-
fusion bridge cycles together with haltered formation of a ring chromosome, chromothripsis, 
chromoanagenesis, as well as at least two cell machineries operating simultaneously. The 
analysis also added further evidence for chromoanagenesis mechanisms underlying the 
formation of both “simple” and highly complex chromosomal rearrangements.  
 
Figure 17. Schematic picture of Alu-Alu mediated rearrangement. Case P2109_123 from 
paper V harbored a DEL-INV-DEL rearrangement (copy number state is indicated in black 
for normal copy number and red for copy number loss, inverted segments are indicated with 
an arrow). Analysis of the breakpoint junctions revealed an Alu-Alu fusion in junction A-C 
and all breakpoints were located within Alu elements (AluSx, AluSq2 and AluSx1). The figure 
is adapted and modified from paper V.
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5 CONCLUDING REMARKS 
 
All studies included in this thesis have focused on detailed characterization of structural 
genomic variants to understand their role in human disease as well as underlying mechanisms 
of formation, in the hope to identify new or previously known disease genes that could 
explain the clinical symptoms and understand how, when, and why the rearrangements 
occurred. The following conclusions can be drawn from these studies: 
§ Whole genome sequencing of both seemingly balanced and complex SVs will add 
valuable information such as positional information, especially for duplications, and 
orientation of copy number neutral genomic segments. In a single experiment, it is 
possible to resolve the complete structure of many chromosomal rearrangements and 
identify cryptic aberrations not detected on microarray, such as inversions, 
translocations and small imbalances in the breakpoints. This added information is 
highly clinically relevant in many cases, and hence WGS is an important 
complementary method to aCGH, which is still the first screening method for SVs in 
clinical diagnostics. 
§ Reciprocal translocations are likely more commonly mediated by errors during DNA 
replication than what has previously been described and mechanisms involving 
template switiching might contribute to the formation of up to 17% of reciprocal 
translocations. 
§ Small intragenic duplications are rare, but important, human disease causing alleles. 
Targeted microarray analysis or whole-genome sequencing may be used to identify 
such small structural variants in a screening setting. 
§ Complex genomic rearrangements are commonly classified according to the 
mutational signatures in the breakpoint junctions, as well as whether the 
rearrangements involve deletions, duplications, or both. However, it is important to 
also perform detailed analysis of the parents that may carry a rearrangement that 
could have promoted the formation of the disease-causing rearrangement. 
§ Non-allelic homologous recombination (NAHR) is likely not the major mechanism 
underlying the formation of cytogenetically detected chromosomal inversions. 
Instead, our data suggests that most inversions show mutational signatures consistent 
with non-homologous end-joining, similar to what is seen in reciprocal translocations. 
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6 FUTURE PERSPECTIVES 
 
Today, many of the monogenic disease-causing genes have been identified. Despite this fact, 
it is still difficult to prove that a particular gene is affected when no coding sequence variants 
are identified. De novo structural variants are quite common findings in developmental 
disorders, but assigning function to non-coding variation is and will continue to be a major 
challenge in human genetics. Additionally, to identify the genetic cause of phenotypes such 
as isolated intellectual disability and autism is still a demanding task. As mentioned 
previously, the numbers of mildly affected balanced chromosomal aberration carriers are 
unknown, and we most likely will continue to discover new candidate disease genes by 
looking thoroughly at apparently balanced chromosomal rearrangements, both with directly 
affected genes but also with position effects caused by the physical change of the 3D 
structure of the genome.  
In addition, the continuous investigation of the underlying mechanisms of SV formation will 
help understanding the biological mechanisms underlying chromosomal rearrangements and 
using whole genome sequencing for exact pinpointing of breakpoint junctions provides the 
potential of discovering new biological mechanisms in genome stability and instability. 
As WGS continues to be implemented in the clinical setting, we will continue to find new 
SVs that would not have been detected using cytogenetic tools. The clinical impact of these 
variants needs to be thoroughly studied, and for correct interpretation positional information, 
breakpoint junction architecture and resolution at nucleotide level is needed. In the clinical 
setting, it is of high importance to be able to filter out the normal variation of the genome 
from the rare and potentially pathogenic variants. To use WGS as a screening method for 
SVs, the databases of normal variation will have to be larger and include more populations, 
and bioinformatics tools to handle the massive amounts of data need to be optimized. 
In conclusion, by understanding the mechanisms underlying structural variants formation we 
will also provide clues to how such events re-organize the human 3D genome and change 
expression of disease genes, with or without interfering with the coding sequence. In 
addition, WGS data will provide with clinically relevant information such as positional 
information, adding valuable information needed for clinical evaluation of the variants. 
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7 SAMMANFATTNING PÅ SVENSKA 
 
En strukturell kromosomavvikelse innebär att den fysiska strukturen på en kromosom har 
förändrats på något sätt. Kopietalsavvikelser, så kallade copy number variants (CNVs) 
innebär att delar av kromosomen fattas (deletioner) eller har kopierats upp fler gånger än 
normalt (duplikationer/triplikationer). Eftersom dessa kromosomavvikelser innebär att 
genetiskt material har tillkommit eller fattas, kallas de obalanserade. Andra strukturella 
kromosomavvikelser kan innefatta fler än en kromosom, där delar av två eller fler 
kromosomer har gått av och bytt plats (translokationer), att en och samma kromosom gått av 
på två ställen och kromosommaterialet mellan brottspunkterna vridit sig 180° (inversion) 
eller att en bit av en kromosom brutit sig loss och satt sig på ett annat ställe (insertion). Dessa 
typer av kromosomavvikelser genererar vanligtvis ingen tillkomst eller förlust av genetiskt 
material och kallas därför balanserade. Riktigt komplexa kromosomavvikelser innehåller 
flertalet brottspunkter, ibland över hundra, och kan innefatta både obalanserade och 
balanserade strukturella varianter.  
Bärare av balanserade strukturella kromosomavvikelser är ofta helt friska och 
rearrangemangen av kromosomerna upptäcks ofta först vid kromosomutredning på grund av 
infertilitet eller upprepade spontana aborter. Dessa beror ofta på att det balanserade 
kromosomrearrangemanget kan dela sig på flera olika sätt i könscellerna och på så sätt ibland 
orsaka obalanserade kromosomavvikelser hos fostret. I mycket ovanliga fall orsakar ändå en 
till synes balanserad kromosomavvikelse medicinska problem på grund av att viktiga 
arvsanlag (gener) ligger precis i brottspunkterna. Dessa har tidigare inte kunnat upptäckas på 
grund av för låg upplösning på metoderna som använts, men numera kan vi ofta hitta 
brottspunkterna på kromosomavvikelser ner på basparsnivå. Metoden som möjliggör detta 
kallas för helgenomsekvensering och innebär att vi genom ett enda experiment kan 
sekvensera hela arvsmassan (cirka 3 miljarder baspar innehållande cirka 20-25 000 gener) 
och pussla ihop allt genetiskt material för att förstå hur kromosomavvikelser sitter ihop och 
hur de kan ha uppstått.  
Det finns ett flertal teorier kring uppkomstmekanismerna för kromosomavvikelser och de 
olika mekanismerna har distinkta ”signaturer” som kan avslöjas av sekvenserna kring 
brottspunkterna och där kromosombitarna limmats ihop. Ett flertal kända 
kromosomavvikelser uppstår gång på gång hos obesläktade individer, och det beror på så 
kallade repetitiva sekvenser. Mindre än 2% av allt DNA hos människan kodar för protein, 
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resten är så kallat ”ickekodande” genetiskt material som vi inte vet så mycket om ännu. Detta 
genetiska material innehåller stora delar sekvens som upprepas flera gånger och alltså finns 
på flera platser i genomet. När dessa sekvenser kommer för nära varandra, kan maskineriet 
som kopierar och reparerar DNA blanda ihop sekvenserna och kopiera/reparera DNA på ett 
felaktigt sätt. Detta kan då leda till att bitar av DNA förloras eller kopieras upp för många 
gånger, vilket kan orsaka sjukdomar ifall gener som är känsliga för kopietalsavvikelser är 
involverade. 
Komplexa kromosomavvikelser med många brottspunkter kan uppstå genom flertalet olika 
mekanismer, där de två vanligaste innebär antingen en ”nybildning” av kromosomen där 
maskineriet för kopiering och reparation av DNA gör upprepade misstag 
(chromoanasynthesis), eller en ”kromosomkatastrof” där kromosomen av olika anledningar i 
det närmaste pulveriseras och därefter pusslas samman i en till synes helt slumpmässig 
ordning (chromothripsis). 
Att förstå sambandet mellan DNA-struktur och hur kromosomavvikelser uppstår är helt 
avgörande för att kunna ge personer och familjer med kromosomavvikelser rätt vägledning 
och hjälp. Att få en diagnos har ofta stor inverkan på patientens och den närmaste familjens 
situation genom möjlighet till anlagstestning och fosterdiagnostik. Om vi förstår hur, var, när 
och varför kromosomavvikelser uppstår, kan vi även ge korrekt vägledning för exempelvis 
upprepningsrisk vid nya graviditeter. I vissa fall kan även rätt diagnos ge möjlighet till 
medicinsk behandling för att lindra eller bota symptom.  
Syftet med denna avhandling har varit att försöka förstå de bakomliggande 
uppkomstmekanismer som orsakar kromosomavvikelser samt identifiera både nya och 
tidigare kända sjukdomsorsakande gener. Sammanfattningsvis visar resultaten att misstag 
under DNA-replikation troligtvis är en vanligare underliggande uppkomstmekanism för 
balanserade kromosomavvikelser än vad som tidigare rapporterats. Avhandlingen visar även 
tydligt att helgenomsekvensering är en mycket viktig metod för att kunna definiera och 
analysera kromosomavvikelser på djupet. På lång sikt kan fynden förhoppningsvis vara till 
hjälp för att ge fler patienter rätt diagnos och fler familjer hjälp med anlagstest, 
fosterdiagnostik och vägledning.
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